171 related articles for article (PubMed ID: 1634535)
21. Inhibited thrombins. Interactions with fibrinogen and fibrin.
Kaminski M; McDonagh J
Biochem J; 1987 Mar; 242(3):881-7. PubMed ID: 3593282
[TBL] [Abstract][Full Text] [Related]
22. Ratcheting of the substrate from the zymogen to proteinase conformations directs the sequential cleavage of prothrombin by prothrombinase.
Bianchini EP; Orcutt SJ; Panizzi P; Bock PE; Krishnaswamy S
Proc Natl Acad Sci U S A; 2005 Jul; 102(29):10099-104. PubMed ID: 16006504
[TBL] [Abstract][Full Text] [Related]
23. Structures of the noncovalent complexes of human and bovine prothrombin fragment 2 with human PPACK-thrombin.
Arni RK; Padmanabhan K; Padmanabhan KP; Wu TP; Tulinsky A
Biochemistry; 1993 May; 32(18):4727-37. PubMed ID: 8387813
[TBL] [Abstract][Full Text] [Related]
24. Opioid receptor labeling with the chloromethyl ketone derivative of [3H]Tyr-D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO) II: Covalent labeling of mu opioid binding site by 3H-Tyr-D-Ala-Gly-(Me)Phe chloromethyl ketone.
Oktem HA; Moitra J; Benyhe S; Toth G; Lajtha A; Borsodi A
Life Sci; 1991; 48(18):1763-8. PubMed ID: 1850495
[TBL] [Abstract][Full Text] [Related]
25. Allosteric changes in solvent accessibility observed in thrombin upon active site occupation.
Croy CH; Koeppe JR; Bergqvist S; Komives EA
Biochemistry; 2004 May; 43(18):5246-55. PubMed ID: 15122890
[TBL] [Abstract][Full Text] [Related]
26. The refined 1.9-A X-ray crystal structure of D-Phe-Pro-Arg chloromethylketone-inhibited human alpha-thrombin: structure analysis, overall structure, electrostatic properties, detailed active-site geometry, and structure-function relationships.
Bode W; Turk D; Karshikov A
Protein Sci; 1992 Apr; 1(4):426-71. PubMed ID: 1304349
[TBL] [Abstract][Full Text] [Related]
27. Evidence that catalytically-inactivated thrombin forms non-covalently linked dimers that bridge between fibrin/fibrinogen fibers and enhance fibrin polymerization.
Mosesson MW; Hernandez I; Siebenlist KR
Biophys Chem; 2004 Jul; 110(1-2):93-100. PubMed ID: 15223147
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of inhibitor constants and alkylation rates for a series of thrombin affinity labels.
Walker B; Wikstrom P; Shaw E
Biochem J; 1985 Sep; 230(3):645-50. PubMed ID: 4062869
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of subtilisin BPN' with peptide chloromethyl ketones.
Powers JC; Lively MO; Tippett JT
Biochim Biophys Acta; 1977 Jan; 480(1):246-61. PubMed ID: 831835
[TBL] [Abstract][Full Text] [Related]
30. Evidence for common structural changes in thrombin induced by active-site or exosite binding.
Parry MA; Stone SR; Hofsteenge J; Jackman MP
Biochem J; 1993 Mar; 290 ( Pt 3)(Pt 3):665-70. PubMed ID: 8457193
[TBL] [Abstract][Full Text] [Related]
31. Role of regulatory exosite I in binding of thrombin to human factor V, factor Va, factor Va subunits, and activation fragments.
Dharmawardana KR; Olson ST; Bock PE
J Biol Chem; 1999 Jun; 274(26):18635-43. PubMed ID: 10373475
[TBL] [Abstract][Full Text] [Related]
32. Structural and functional properties of human alpha-thrombin, phosphopyridoxylated alpha-thrombin, and gamma T-thrombin. Identification of lysyl residues in alpha-thrombin that are critical for heparin and fibrin(ogen) interactions.
Church FC; Pratt CW; Noyes CM; Kalayanamit T; Sherrill GB; Tobin RB; Meade JB
J Biol Chem; 1989 Nov; 264(31):18419-25. PubMed ID: 2509458
[TBL] [Abstract][Full Text] [Related]
33. Unfractionated heparin inhibits thrombin-catalysed amplification reactions of coagulation more efficiently than those catalysed by factor Xa.
Ofosu FA; Hirsh J; Esmon CT; Modi GJ; Smith LM; Anvari N; Buchanan MR; Fenton JW; Blajchman MA
Biochem J; 1989 Jan; 257(1):143-50. PubMed ID: 2920007
[TBL] [Abstract][Full Text] [Related]
34. Role of prothrombin fragment 1 in the pathway of regulatory exosite I formation during conversion of human prothrombin to thrombin.
Anderson PJ; Bock PE
J Biol Chem; 2003 Nov; 278(45):44489-95. PubMed ID: 12939270
[TBL] [Abstract][Full Text] [Related]
35. Mechanism of the reaction of papain with substrate-derived diazomethyl ketones. Implications for the difference in site specificity of halomethyl ketones for serine proteinases and cysteine proteinases and for stereoelectronic requirements in the papain catalytic mechanism.
Brocklehurst K; Malthouse JP
Biochem J; 1978 Nov; 175(2):761-4. PubMed ID: 743223
[TBL] [Abstract][Full Text] [Related]
36. Affinity labeling of the catalytic subunit of cyclic AMP-dependent protein kinase by N alpha-tosyl-L-lysine chloromethyl ketone.
Kupfer A; Gani V; Jiménez JS; Shaltiel S
Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3073-7. PubMed ID: 226953
[TBL] [Abstract][Full Text] [Related]
37. Kinetics of hydrolysis of peptide thioester derivatives of arginine by human and bovine thrombins.
Cook RR; McRae BJ; Powers JC
Arch Biochem Biophys; 1984 Oct; 234(1):82-8. PubMed ID: 6486828
[TBL] [Abstract][Full Text] [Related]
38. Interaction of dansylated peptidyl chloromethanes with trypsin, chymotrypsin, elastase, and thrombin.
Penny GS; Dyckes DF
Biochemistry; 1980 Jun; 19(13):2888-94. PubMed ID: 6901612
[TBL] [Abstract][Full Text] [Related]
39. Novel fluorescent prothrombin analogs as probes of staphylocoagulase-prothrombin interactions.
Panizzi P; Friedrich R; Fuentes-Prior P; Kroh HK; Briggs J; Tans G; Bode W; Bock PE
J Biol Chem; 2006 Jan; 281(2):1169-78. PubMed ID: 16230340
[TBL] [Abstract][Full Text] [Related]
40. Human D-Phe-Pro-Arg-CH2-alpha-thrombin crystallization and diffraction data.
Skrzypczak-Jankun E; Rydel TJ; Tulinsky A; Fenton JW; Mann KG
J Mol Biol; 1989 Apr; 206(4):755-7. PubMed ID: 2738917
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
